Relapses in multiple sclerosis: important or not?
نویسندگان
چکیده
published by Anonymous (not verified) on Tue, 10/08/2013 10:39am Title Relapses in multiple sclerosis: important or not? Publication Type Journal Article Year of Publication 2009 Authors Marrie, RAnn, Cutter, G Journal Neurology Volume 73 Issue 20 Pagination 1612-3 Date Published 2009 Nov 17 ISSN 1526-632X
منابع مشابه
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis
Introduction: Multiple Sclerosis (MS) is primarily a disease of women in their childbearing years. Risk for postpartum relapse is increased in the first 3 months after delivery. Previous studies of breastfeeding and postpartum relapse showed little or no benefit, but none examined exclusive breastfeeding. Methods: In this review article, electronic searches were undertaken in PubMed, Scholar...
متن کاملپارامترهای بالینی، روانشناختی و جمعیت‌شناختی درد بدنی در مولتیپل اسکلروزیس
Background: Body pain in multiple sclerosis (MS) is a common phenomenon that can create or exacerbate by different parameters of clinical, psychological and demographic. The aim of this study was to investigate the relationship between parameters of clinical (fatigue, clinical course, body mass index and duration), psychological (depression, anxiety and stress) and demographic (age, gender, mar...
متن کاملReview of New Methods of Diagnosis and Treatment of Multiple Sclerosis
Multiple sclerosis (MS) is a demyelinating process involving mainly the white matter of central nervous system. The clinical diagnosis generally rests on two features of the illness: A. A history of fluctuations in the clinical course. B. A physical examination consistent with that of multiple lesionsjinllheiwhite matter o,f the central nervous system. No specific laboratory test is cur...
متن کاملRelapse management in multiple sclerosis.
Relapses, exacerbations, and attacks are synonymous for new or worsened neurologic symptoms that are the hallmark of relapsing-remitting multiple sclerosis. Management of relapses is not always straightforward. The clinician must distinguish between true relapses, symptom fluctuation, and pseudo-relapses. Risks and benefits of treating a relapse must be considered. Once the decision to treat is...
متن کاملFingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial
Background: High dose Interferon Beta and Fingolimod are efficient in Multiple Sclerosis. Objectives: Comparison the efficacy of these two drugs in patients with treatment failure on low dose interferon beta. Materials and Methods: The MS patients (McDonald criteria 2010) with the history of unbeneficial treatment on low dose interferon beta participated in this randomized clinical trial ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Neurology
دوره 73 20 شماره
صفحات -
تاریخ انتشار 2009